Healthcare operations

Canada’s drug regulator has issued a final positive review supporting public reimbursement of Leqembi (lecanemab) for early Alzheimer’s disease, marking a significant policy shift.

• Lifevest Advisors Team
• September 1, 2026

HUTCHMED announces that the SANOVO trial shows notable progression-free survival benefits for ORPATHYS® combined with TAGRISSO® in lung cancer patients in China.

• Lifevest Advisors Team
• August 31, 2026

Aleya Experts highlight how advanced laser technology and expertise improve safety and effectiveness of hair removal for darker skin tones.

• Lifevest Advisors Team
• August 28, 2026

Biosidus has announced a significant expansion of its biologics manufacturing capacity to enhance global supply of agalsidase beta, improving access worldwide.

• Lifevest Advisors Team
• August 27, 2026

A new brain signal monitoring technology aims to detect health safety risks early, offering a role-filtered alert system for consumer brands.

• Thorsten Meyer
• August 26, 2026

A new app uses phone-camera technology to objectively measure teeth shade, helping consumers track whitening progress and choose effective products.

• Thorsten Meyer
• August 25, 2026

Orum Therapeutics announced FDA clearance for an IND application for ORM-115, a novel CD123-GSPT1 degrader-antibody conjugate, advancing its clinical pipeline.

• Lifevest Advisors Team
• August 23, 2026

New AI-driven system uses photos to verify food safety in restaurant kitchens, replacing manual checklists and enhancing compliance.

• Thorsten Meyer
• August 21, 2026

LabCorp Holdings has filed an 8-K with the SEC announcing an executive departure. Details are limited, and the company has not disclosed the successor.

• Lifevest Advisors Team
• August 14, 2026

New approach uses daily phone photos of gum lines to detect early inflammation, aiding preventive dental care and patient engagement.

• Thorsten Meyer
• August 11, 2026